Artivion, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 298.84M | 313.79M | 354.00M | 388.54M | 441.33M | 13.6% | |
| Cost of Revenue | (101.32M) | (111.27M) | (124.83M) | (139.76M) | (170.88M) | 22.3% | |
Gross Profit | 197.51M | 202.52M | 229.18M | 248.78M | 270.45M | 8.7% | |
| Operating Expenses | |||||||
| Research & Development | (35.55M) | (38.88M) | (28.71M) | (28.45M) | (30.99M) | 8.9% | |
| Selling, General & Administrative | (169.77M) | (157.44M) | (208.98M) | (192.38M) | (212.72M) | 10.6% | |
| Depreciation & Amortization | (23.98M) | (22.44M) | (23.08M) | (24.20M) | (22.46M) | -7.2% | |
Operating Income (EBIT) | 8.12M | 6.20M | 5.74M | 38.87M | 26.75M | -31.2% | |
| Non-Operating Items | |||||||
| Interest Income | 79.00K | 147.00K | 1.08M | 1.47M | 763.00K | -48.0% | |
| Interest Expense | (16.89M) | (18.22M) | (25.30M) | (34.28M) | (26.58M) | -22.4% | |
| Other Income/Expenses (Net) | -22.94M | -21.18M | -27.33M | -46.39M | -11.96M | -74.2% | |
Income Before Tax | -14.83M | -14.98M | -21.59M | -7.51M | 14.78M | -296.7% | |
| Income Tax Expense | (7.00K) | (4.21M) | (9.10M) | (5.84M) | (5.01M) | -14.3% | |
Net Income | -14.83M | -19.19M | -30.69M | -13.36M | 9.77M | -173.1% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-0 | $-0 | $-1 | $-0 | $0 | -168.8% | |
| Weighted Avg Shares Outstanding | 38.98M | 40.03M | 40.74M | 41.68M | 45.34M | 8.8% | |
| Weighted Avg Shares Outstanding (Diluted) | 38.98M | 40.03M | 40.74M | 41.68M | 47.16M | 13.2% | |
EBITDA | 26.04M | 25.68M | 26.79M | 50.97M | 63.82M | 25.2% |
Explore AORT
AORT in the Healthcare
Small Cap